informaworld logo
HOME . ABOUT US . CONTACT US 		HELP . PUBLISH WITH US . LIBRARIANS 
ebooks logo journals logo reference works logo abstract databases logo
bullet  SIGN IN Register | Why Register? | Got a Voucher? alerts   marked lists   shopping cart 
Session timed out - new session started. You may need to sign in again. [ hide message ]
Advert: Informa Healthcare - http://www.informahealthcare.com

informaworld

HOME   |   SEARCH   |   BROWSE
    Issues List       Latest Issue       Forthcoming Articles       Volume 46 Issue 2       Aims & Scope       Editorial Board       Instructions for Authors       Subscribe      
<< earliestearliest   < prevprev   Issue listissues   next >next   latest >>latest
Publisher Logo Publication Cover
Search within this journal

Acta Oncologica, Volume 46 Issue 2 2007

Acta Oncologica is moving!


2008 Impact Factor: 2.739 (ISI Web of Knowledge, 2008 Journal Citation Report)
Online content older than 6 months is available for full text dowload
ISSN: 1651-226X (electronic) 0284-186X (paper)
Publication Frequency: 8 issues per year
Subject: Oncology;
You have: FREE ACCESS FREE ACCESS
Viewing the Journal: Select the initial letter of your research topic from the list below, or enter your search term on the left.
Sort by: Title | Page | Author
< Previous • 1 • 2 • Next >
View new articles ahead of the print edition
select-down Click for help
ORIGINAL ARTICLE
Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer
Lars E. Rutqvist;  Hemming Johansson; on behalf of the Stockholm Breast Cancer Study Group
Pages 133 – 145
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: Is tailored and dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than marrow-supported high-dose chemotherapy – results from a randomized study
P. Kellokumpu-Lehtinen;  J. Bergh;  E. Salminen;  T. Wiklund;  S. Lehtinen;  P. Aronen; H. Sintonen
Pages 146 – 152
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis
J. Norum;  J. A. Olsen;  E. A. Wist; P. E. Lønning
Pages 153 – 164
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer
Henrik Lindman;  Gunnar Åström;  Johan Ahlgren;  Kenneth Villman;  Carl Blomqvist;  Peter Nygren; Jonas Bergh
Pages 165 – 171
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy
Jan J. Jobsen;  Job Van Der Palen;  Francisca Ong; Jacobus H. Meerwaldt
Pages 172 – 180
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Effect of a vigorous aerobic regimen on physical performance in breast cancer patients — a randomized controlled pilot trial
Riku Nikander;  Harri Sievänen;  Katriina Ojala;  Tiina Oivanen;  Pirkko-Liisa Kellokumpu-Lehtinen; Tiina Saarto
Pages 181 – 186
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer
Ulla Blom-Goldman;  Gunilla Svane;  Berit Wennberg;  Anders Lideståhl; Pehr A. R. M. Lind
Pages 187 – 193
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Cited By | Related Articles 		Free Online Access FREE
Hormone therapy and estrogen receptor expression in breast cancer
E. Isaksson Friman;  M. Mahlman;  B. Nilsson;  L. Skoog;  L. Löfgren;  N. Wilking; E. Von Schoultz
Pages 194 – 198
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations
Anne I. Hagen;  Anna M. Bofin;  Borgny Ytterhus;  Lovise O. Mæhle;  Kjell H. Kjellevold;  Hans O. Myhre;  Pål Møller; Per E. Lønning
Pages 199 – 203
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Oestrogen and progesterone receptor status of individual foci in multifocal invasive ductal breast cancer
V. Garimella;  E. D. Long;  S. L. O'Kane;  P. J. Drew; L. Cawkwell
Pages 204 – 207
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Phase II trial of pegylated liposomal doxorubicin (Caelyx™) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer
Herbert Ulrich-Pur;  Gabriela V. Kornek;  Karin Haider;  Werner Kwasny;  Thomas Payrits;  Nina Dworan;  Laurenz Vormittag;  Dieter Depisch;  Fritz Lang; Werner Scheithauer
Pages 208 – 213
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Nasopharyngeal carcinoma. Treatment planning with IMRT and 3D conformal radiotherapy
Claus A. Kristensen;  Flemming Kjær-Kristoffersen;  Wendy Sapru;  Anne K. Berthelsen;  Annika Loft; Lena Specht
Pages 214 – 220
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor–κB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton
Giannis Mountzios;  Meletios-Athanassios Dimopoulos;  Aristotelis Bamias;  George Papadopoulos;  Efstathios Kastritis;  Konstantinos Syrigos;  George Pavlakis; Evangelos Terpos
Pages 221 – 229
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma
Pehr A. Lind;  Gisela Naucler;  Agneta Holm;  Michael Gubanski; Christer Svensson
Pages 230 – 233
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Multi-centre phase II trial of Thalidomide in the treatment of unresectable hepatocellular carcinoma
Benjamin Chuah;  Robert Lim;  Michael Boyer;  Ai-Bee Ong;  Seng-Weng Wong;  Hwai-Loong Kong;  Michael Millward;  Stephen Clarke; Boon-Cher Goh
Pages 234 – 238
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
Demographic, clinical and treatment related predictors for event-free probability following low-dose radiotherapy for painful heel spurs – a retrospective multicenter study of 502 patients
Ralph Muecke;  Oliver Micke;  Berthold Reichl;  Rainer Heyder;  Franz-Josef Prott;  M. Heinrich Seegenschmiedt;  Michael Glatzel;  Oliver Schneider;  Ulrich Schäfer; Guenther Kundt
Pages 239 – 246
Abstract | References | Full Text PDF | Full Text HTML | Request Permissions
Related Articles 		Free Online Access FREE
select-up

Privacy Policy | Terms & Conditions | Accessibility | RSS
FAQs in: English . Français . Español . 中文（简体和繁體）
© 2009 Informa plc